Article
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: a multicentre study.
Annals of the rheumatic diseases - 1 Aug 2020
Fagni Filippo, Bettiol Alessandra, Talarico Rosaria, Lopalco Giuseppe, Silvestri Elena, Urban Maria Letizia, Russo Paul A J, Di Scala Gerardo, Emmi Giacomo, Prisco Domenico
Abstract excerpt
OBJECTIVE: To evaluate the effectiveness and safety of secukinumab in patients with a mucosal and articular Behçet's phenotype resistant to conventional and biologic treatment. METHODS: A multicentre retrospective study was performed on 15 patients with a mucosal and articular phenotype of Behçet's syndrome fulfilling the International Criteria for Behçet's Disease and refractory to treatment with colchicine,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.